Silvia Herrera-León

Silvia Herrera-León

Auto-generated profile, based on publicly available information

Silvia Herrera-León

Centro Nacional de Microbiología. Ciber de Epidemiología y Salud Pública (CIBERESP).Instituto de Salud Carlos III (ISCIII)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
AHAndreas Hoefer
Andreas Hoefer
DPDespina Pampaka
Despina Pampaka
SHSilvia Herrera-León
Silvia Herrera-León
SPSonia Peiró
Sonia Peiró
SVSarai Varona
Sarai Varona
LHLaura Herrera-León
Laura Herrera-León
This study examines the microbiological and epidemiological characteristics of toxigenic and nontoxigenic Corynebacterium isolates submitted to the national reference laboratory in Spain, between 2014 and 2019, in order to describe the current situation and improve our knowledge regarding these emerging pathogens. Epidemiological information was extracted from the Spanish Surveillance System.

2 April 2025 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
CCClara Samper Cativiela
Clara Samper Cativiela
LFLaura Torre Fuentes
Laura Torre Fuentes
BDBernabé Diéguez-Roda
Bernabé Diéguez-Roda
MMMargo Maex
Margo Maex
MRMaría Ugarte Ruiz
María Ugarte Ruiz
JAJulio Alvarez
Julio Alvarez
Salmonella Enteritidis, the most prevalent serovar-causing human gastroenteritis, has been traditionally linked to poultry sources. Although antimicrobial resistance (AMR) is not common in this serovar, increasing levels of resistance to fluoroquinolones and ampicillin have been reported in the last few years. Here, 298 isolates retrieved from different sources (human, livestock, wildlife, food, and environment) and years (2002–2021) in Spain were analyzed to evaluate their diversity, the distribution of AMR-conferring genes (ARGs), and mutations and reconstruct the epidemiology of infection due to this serovar. Isolates were clustered in two major clades (I and II), with strains in clade I (including 61.5% of all human isolates) displaying a pan-susceptible phenotype and not carrying AMR determinants. In contrast, clade II included 80.7% of isolates from animal/food/environmental sources, with the majority (69.8%) harboring mutations in the quinolone resistance determinant regions (QRDR). ARGs, although rare, were mostly found in clade II strains that also carried plasmid replicons, among which IncX1 was the most common. Although higher levels of phenotypic resistance were found in animal isolates, extended-spectrum beta-lactamase, plasmid-mediated AmpC, and carbapenemase-encoding genes were only found among human isolates. In summary, the majority of human and animal isolates from Spanish sources in our collection were classified in different phylogenetic branches, suggesting that additional sources are contributing to the occurrence of foodborne infections in Spain. Furthermore, the different distributions of virulence factors and ARGs in isolates from different sources and their association with specific plasmids suggest the presence of different dynamics contributing to the selection of resistant strains.

30 April 2021 in EKAIA Euskal Herriko Unibertsitateko Zientzia eta Teknologia Aldizkaria
Verified
Journal Article
Open access
PDF file
AAAinhoa Arrieta-Gisasola
Ainhoa Arrieta-Gisasola
JBJoseba Bikandi
Joseba Bikandi
Javier Garaizar CandinaJavier Garaizar Candina
Javier Garaizar Candina
SHSilvia Herrera-León
Silvia Herrera-León
Lorena LaordenLorena Laorden
Lorena Laorden
Salmonelosia, herrialde garatuetako toxiinfekzio ohikoenetariko bat da, Salmonella generoko bakterioek eragindakoa. Oro har, giza salmonelosia elikagai kutsatuekin lotzen da. Hala ere, animaliekin izandako kontaktua Salmonella generoaren transmisio bide garrantzitsua izan daiteke. Dortokak Salmonella serotipo desberdinen gordailuak direla frogatu da. Narrasti hauek etxeko maskota oso ohikoak direla kontuan izanda, osasun publikorako arriskutsuak izan daitezke, batez ere haurren artean. Horregatik, lan honetan 4,5,12:b:- formula antigenikoa duen serotipo monofasiko berri bat karakterizatu da. Aztertutako isolatu gehienak 5 urtetik beherako haurretan isolatu dira, Espainiako eskualde desberdinetan. Teknika molekular ezberdinen bidez, baieztatu da 4,5,12:b:- isolatuak Paratyphi B Javako iso- latu bifasikoekin genetikoki erlazionatuta daudela eta serotipo hori dela haren arbaso posiblea. Aztertutako anduien arteko homogeneotasun handiak iradokitzen du, andui horietaz infektatutako dortoken jatorria estuki lotuta dagoela, Espainian dortoken saltokiek banaketa-puntu komuna dutela, eta horrek patogeno honen sakabanaketan laguntzen duela.

30 June 2025 in Boletín epidemiológico semanal
Verified
Journal Article
Open access
ITIvonne Torres-Jiménez
Ivonne Torres-Jiménez
SHSilvia Herrera-León
Silvia Herrera-León
LHLaura Herrera-León
Laura Herrera-León
JMJosefa Masa-Calles
Josefa Masa-Calles
Introducción: La difteria es una enfermedad bacteriana prevenible por vacunación que afecta principalmente al tracto respiratorio superior, con una letalidad que alcanza hasta el 10%. En España la vacuna DTP (difteria, tétanos y tos ferina) se introdujo en 1965 y actualmente cuenta con coberturas > 95%. La difteria es infrecuente en nuestro país, pero en la Unión Europea, en los últimos años se ha registrado un aumento de casos en hombres asociados a centros de recepción de migrantes. Métodos: Estudio epidemiológico descriptivo de los casos de difteria notificados a la Red Nacional de Vigilancia Epidemiológica (RENAVE) entre 2014 y 2024. Las variables estudiadas fueron: edad, sexo, país de nacimiento, país de importación, especie, manifestación clínica, vacunación, defunción y estudio de contactos. Resultados: Entre 2014 y 2024 se notificaron 15 casos de difteria a la RENAVE. La mayoría (73,3%) hombres, 33,3% de 25 a 44 años, 73,3% causados por C. diphtheriae y el 33,3% importados. El 53,3% de los casos se hospitalizaron y una persona falleció. Discusión: La difteria en España es infrecuente gracias a las altas coberturas de vacunación mantenidas desde 1999. Los datos presentados muestran difterias leves en adultos no vacunados o parcialmente vacunados. El agente causal más frecuente es C. diphtheriae aunque, también se han declarado casos producidos por C. ulcerans de origen zoonótico. Es esencial mantener altas coberturas de vacunación, protocolos y sistemas de vigilancia actualizados, incluidos los planes de acogida a personas migrantes.

24 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ENElisabeth Njamkepo
Elisabeth Njamkepo
SDSusann Dupke
Susann Dupke
TTThamida Tauhid
Thamida Tauhid
RSRoger Stephan
Roger Stephan
BPBoas van der Putten
Boas van der Putten
FWFrançois-Xavier Weill
François-Xavier Weill
Background: Following the global resurgence of cholera in 2022, 51 cholera cases were reported by European countries. We previously characterised 49 Vibrio cholerae O1 isolates from these cases using whole genome sequencing. In 2023 and 2024, 59 additional cholera cases were reported by 11 European countries. Aim: We aimed to confirm that V. cholerae O1 isolates associated with cholera cases reported in Europe in 2023–2024 belonged to the epidemic seventh pandemic El Tor (7PET) lineage rather than to non-epidemic V. cholerae O1 lineages, and to characterise their virulence, antimicrobial resistance (AMR) determinants and phylogenetic relationships. Methods: Fifty V. cholerae O1 isolates were available for whole genome sequencing, of which 49 yielded genomes of sufficient quality for analysis. Genomes were analysed together with more than 1,500 publicly available 7PET genomes to place the European isolates into a global phylogenetic context. Results: All 49 genomes belonged to the 7PET lineage and Wave 3. Four sub-lineages were identified: BD1.2 (2/49), AFR12 (6/49), AFR13 (8/49) and Pre-AFR15 (33/49). The predominance of Pre-AFR15 confirms its continued contribution to the ongoing global cholera resurgence. In contrast to our 2022 survey, eight highly drug-resistant AFR13 isolates were detected, documenting the international spread of this highly drug-resistant clone resistant to multiple first-line antimicrobial agents. Conclusion: Whole genome sequencing should be routinely used by reference laboratories to distinguish epidemic 7PET from non-epidemic V. cholerae O1 lineages and to monitor the emergence and international spread of AMR clones. Continued collaborative genomic surveillance of travel-associated cholera cases can provide early insights into the emergence, international spread and antimicrobial resistance of 7PET sub-lineages.